These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21327452)

  • 41. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
    Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
    Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells.
    Hann A; Gruner A; Chen Y; Gress TM; Buchholz M
    PLoS One; 2011; 6(6):e20859. PubMed ID: 21698183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer.
    Siddiqui GK; Elmasry K; Wong Te Fong AC; Perrett C; Morris R; Crow JC; Maclean AB
    Eur J Gynaecol Oncol; 2010; 31(2):156-9. PubMed ID: 20527230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
    Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of galectin-3 expression in mucinous colorectal carcinomas is associated with 5'CpG island methylation in Tunisian patients.
    Mahmoud LK; Arfaoui A; Khiari M; Chaar I; El Amine O; Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):258-65. PubMed ID: 21494181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
    Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin.
    Umezu T; Shibata K; Kajiyama H; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Gynecol Pathol; 2008 Apr; 27(2):207-12. PubMed ID: 18317222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma.
    Beussel S; Hasenburg A; Bogatyreva L; Hauschke D; Werner M; Lassmann S
    J Clin Pathol; 2012 Jan; 65(1):29-35. PubMed ID: 22011448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
    Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
    BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor.
    Sönmezer M; Güngör M; Ensari A; Ortaç F
    Int J Gynecol Cancer; 2004; 14(1):82-8. PubMed ID: 14764033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.
    Previs R; Leath CA; Coleman RL; Herzog TJ; Krivak TC; Brower SL; Tian C; Secord AA
    Gynecol Oncol; 2015 Aug; 138(2):267-71. PubMed ID: 26037898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GAL3 protein expression is related to clinical features of prolactin-secreting pituitary microadenoma and predicts its recurrence after surgical treatment.
    Dai D; Li Y; Lu Q; Yu L; Min W; Wang L; Cao Y; Yue Z
    Cell Physiol Biochem; 2014; 33(4):1026-35. PubMed ID: 24732466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer.
    Sun X; Zhang W; Li H; Niu C; Ou Y; Song L; Zhang Y
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.